Table 3.
< 75 | ≥ 75 | |||
---|---|---|---|---|
Variable | Model 1: Unadjusted (n=1,381) | Model 5: Models 2, 3 & 4 + Comorbidities (n=1,372) | Model 1: Unadjusted (n=498) | Model 5: Models 2, 3 & 4 + Comorbidities (n=493) |
Process of Care Measures † | 0.88 (0.69–1.13) | 0.84 (0.65–1.09) | 0.82 (0.64–1.06)* | 0.72 (0.55–0.93)* |
Female | 0.64 (0.51–0.82)* | 0.69 (0.52–0.90)* | ||
Less than HS | 1.14 (0.89–1.45) | 0.98 (0.76–1.28) | ||
Single | 1.31 (1.01–1.70)* | 1.27 (0.96–1.67) | ||
<50k | 1.10 (0.71–1.70) | 1.31 (0.81–2.12) | ||
50–535k | 1.11 (0.75–1.65) | 1.50 (0.97–2.32) | ||
1 or More ADL | 1.17 (0.87–1.57) | 1.06 (0.79–1.41) | ||
1 or More IADL | 1.63 (1.21–2.21)* | 1.92 (1.45–2.54)* | ||
Geriatric Conditions | 1.02 (0.91–1.13) | 1.05 (0.95–1.17) | ||
Uses Insulin | 1.19 (0.92–1.54) | 1.16 (0.88–1.53) | ||
TIBI | 1.02 (1.01–1.02)* | 1.01 (1.00–1.02)* |
Process of Care measures include HbA1c test, urine test, eye exam, aspirin counseling, and diabetes education (0=0–2, 1=3–5),
Significant P-Value